A detailed history of Van Eck Associates Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Van Eck Associates Corp holds 27,726 shares of ABT stock, worth $3.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,726
Previous 31,184 11.09%
Holding current value
$3.14 Million
Previous $3.24 Million 0.12%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$100.07 - $118.13 $346,042 - $408,493
-3,458 Reduced 11.09%
27,726 $3.24 Million
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $153,311 - $171,133
1,522 Added 5.13%
31,184 $3.24 Million
Q1 2024

Apr 30, 2024

SELL
$109.52 - $120.96 $1.3 Million - $1.43 Million
-11,841 Reduced 28.53%
29,662 $3.37 Million
Q4 2023

Feb 05, 2024

SELL
$90.19 - $110.4 $20.7 Million - $25.4 Million
-229,700 Reduced 84.7%
41,503 $4.57 Million
Q3 2023

Nov 08, 2023

SELL
$95.53 - $114.62 $166,317 - $199,553
-1,741 Reduced 0.64%
271,203 $26.3 Million
Q2 2023

Aug 03, 2023

BUY
$100.78 - $112.29 $1.25 Million - $1.4 Million
12,426 Added 4.77%
272,944 $29.8 Million
Q1 2023

May 03, 2023

BUY
$96.86 - $114.01 $3.46 Million - $4.07 Million
35,707 Added 15.88%
260,518 $26.4 Million
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $351,436 - $412,289
-3,697 Reduced 1.62%
224,811 $24.7 Million
Q3 2022

Oct 27, 2022

BUY
$96.76 - $112.03 $1.4 Million - $1.62 Million
14,456 Added 6.75%
228,508 $22.1 Million
Q2 2022

Aug 03, 2022

BUY
$102.07 - $123.37 $19 Million - $22.9 Million
185,814 Added 658.03%
214,052 $23.3 Million
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $52,677 - $64,236
462 Added 1.66%
28,238 $3.34 Million
Q4 2021

Jan 26, 2022

BUY
$115.53 - $141.46 $59,151 - $72,427
512 Added 1.88%
27,776 $3.91 Million
Q3 2021

Nov 03, 2021

BUY
$116.66 - $129.06 $366,079 - $404,990
3,138 Added 13.01%
27,264 $3.22 Million
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $9,415 - $11,083
-89 Reduced 0.37%
24,126 $2.8 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $653,801 - $770,277
6,007 Added 32.99%
24,215 $2.9 Million
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $11,130 - $12,128
106 Added 0.59%
18,208 $1.99 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $2.29 Million - $2.78 Million
-25,012 Reduced 58.01%
18,102 $1.97 Million
Q2 2020

Aug 10, 2020

SELL
$76.57 - $98.0 $1.04 Million - $1.33 Million
-13,609 Reduced 23.99%
43,114 $3.94 Million
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $841,662 - $1.23 Million
-13,398 Reduced 19.11%
56,723 $4.48 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $211,662 - $235,630
2,696 Added 4.0%
70,121 $6.09 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $174,646 - $189,371
2,134 Added 3.27%
67,425 $5.64 Million
Q2 2019

Aug 07, 2019

BUY
$72.88 - $85.0 $426,712 - $497,675
5,855 Added 9.85%
65,291 $5.49 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $1.23 Million - $1.48 Million
-18,524 Reduced 23.76%
59,436 $4.75 Million
Q4 2018

Feb 12, 2019

BUY
$65.56 - $74.27 $464,885 - $526,648
7,091 Added 10.01%
77,960 $5.64 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $331,171 - $399,518
5,446 Added 8.32%
70,869 $5.2 Million
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $3.77 Million - $4.16 Million
65,423 New
65,423 $3.99 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.